Hicks P E
Clin Exp Hypertens (1978). 1978;1(2):251-65. doi: 10.3109/10641967809068607.
Centrally induced pressor effects, associated with tachycardia have previously been demonstrated after intraventricular (i.c.v.) injections of histamine. The selective histamine H2-receptor agonists dimaprit (1--500 microgram) and 4-methyl histamine (1--10 microgram), and the histamine H1-receptor agonist 2-methyl histamin (1--10 microgram) elicited rises in blood pressure and heart rate after i.c.v. administration in urethane-anaesthetised rats. Metiamide (400--800 microgram, i.c.v.) antagonised the cardiovascular responses induced by dimaprit and 4-methyl histamine, but not the responses induced by 2-methyl histamine. In contrast mepyramine (100 microgram, i.c.v.) failed to antagonise the dimaprit-induced effects. It is concluded that histamine H1 and H2-receptors are present in the central nervous system of rats. Selective stimulation of either H1- or H2-receptors can lead to pressor effects associated with tachycardia after i.c.v. administration of specific agonists in urethane-anaesthetised rats. These responses are selectively antagonised by the respective receptor antagonists.
先前已证明,脑室内(i.c.v.)注射组胺后会出现与心动过速相关的中枢性升压效应。在氨基甲酸乙酯麻醉的大鼠中,选择性组胺H2受体激动剂二甲双胍(1 - 500微克)和4 - 甲基组胺(1 - 10微克),以及组胺H1受体激动剂2 - 甲基组胺(1 - 10微克)经脑室内给药后会引起血压和心率升高。甲硫咪特(400 - 800微克,脑室内注射)可拮抗二甲双胍和4 - 甲基组胺诱导的心血管反应,但不能拮抗2 - 甲基组胺诱导的反应。相比之下,吡苄明(100微克,脑室内注射)未能拮抗二甲双胍诱导的效应。结论是,组胺H1和H2受体存在于大鼠中枢神经系统中。在氨基甲酸乙酯麻醉的大鼠中,经脑室内注射特定激动剂后,选择性刺激H1或H2受体可导致与心动过速相关的升压效应。这些反应可被相应的受体拮抗剂选择性拮抗。